Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

NCT07640139 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

125000

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Incretin-based therapies (GLP-1 and GLP-1/GIP)

Sponsor

Indiana University

Collaborators

[object Object]